Odili J L, Taylor G
Br Med J. 1971 Dec 4;4(5787):584-6. doi: 10.1136/bmj.4.5787.584.
By examining serial serum samples from patients undergoing surgical removal of malignant tumours an increased incidence of tumour-specific antibodies has been detected. Antibody responses to tumour neoantigens seem to be transient, and this is held to account for the rarity of detections where a single sample of serum is examined.
通过检测接受恶性肿瘤手术切除患者的系列血清样本,已检测到肿瘤特异性抗体的发病率增加。对肿瘤新抗原的抗体反应似乎是短暂的,这被认为是单次检测血清样本时检测结果罕见的原因。